12:00 AM
 | 
Oct 26, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Micardis telmisartan regulatory update

FDA approved an sNDA from Boehringer for Micardis 80 mg telmisartan tablets to reduce the risk of myocardial infarction (MI), stroke and cardiovascular death in high...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >